Alzheimer’s disease (AD) is currently ranked as the sixth leading cause of death in the United States and recent estimates indicate that the disorder may rank third, just behind heart disease and cancer, as a cause of death for older people. Clearly, predicting this disease in the early stages and preventing it from progressing is of great importance. The diagnosis of Alzheimer’s disease (AD) requires a variety of medical tests, which leads to huge amounts of multivariate heterogeneous data. It can be difficult and exhausting to manually compare, visualize, and analyze this data due to the heterogeneous nature of medical tests; therefore, an efficient approach for accurate prediction of the condition of the brain using resting-state functional magnetic resonance imaging (R-fMRI) data. A targeted autoencoder network is built to distinguish normal aging from mild cognitive impairment, an early stage of AD. The proposed method reveals discriminative brain network features effectively and provides a reliable classifier for AD detection. Compared to traditional classifiers based on R-fMRI time series data. The proposed work is also able to classify the different types of Alzheimer’s disease as well as a particular stage of the disease. Finally, we will compare our deep learning approach accuracy with existing systems. In this paper, we proposed a system using deep learning with brain network and clinical relevant text information to make an early diagnosis of Alzheimer’s Disease (AD). The clinical relevant text information includes age, gender and ApoE gene of the subject. The brain network is constructed by computing the functional connectivity of brain regions using resting-state functional magnetic resonance imaging (R-fMRI) data. A targeted autoencoder network is built to distinguish normal aging from mild cognitive impairment, an early stage of AD. The proposed method reveals discriminative brain network features effectively and provides a reliable classifier for AD detection.